Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10120038 | 0.93 | — | — | |
| SCHEMBL13150392 | 0.92 | KDM4E (0.34) | KDM4E | |
| SCHEMBL16084555 | 0.82 | — | — | |
| SCHEMBL19130080 | 0.79 | — | — | |
| SCHEMBL12588607 | 0.78 | — | — | |
| SCHEMBL4782503 | 0.76 | KDM4E (0.33) | KDM4E | |
| SCHEMBL9716544 | 0.76 | KDM4E (0.32) | KDM4E | |
| SCHEMBL113604 | 0.73 | KDM4E (0.33) | KDM4E | |
| SCHEMBL19477973 | 0.72 | KDM4E (0.35) | KDM4E | |
| SCHEMBL12891508 | 0.72 | KDM4E (0.35) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9139753-B2 | Single-component moisture-curable coatings based on N-substituted urea polymers with extended chains and terminal alkoxysilanes | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140275405-A1 | SINGLE-COMPONENT MOISTURE-CURABLE COATINGS BASED ON N-SUBSTITUTED UREA POLYMERS WITH EXTENDED CHAINS AND TERMINAL ALKOXYSILANES | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2014-09-18 | — | — | US | disclosed |
| US-20110190455-A1 | POLYDIALKYLSILOXANE-BRIDGED BI-PHOTOCHROMIC MOLECULES | Vivimed Labs Europe Ltd. (GB) | 2011-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190455-A1 | POLYDIALKYLSILOXANE-BRIDGED BI-PHOTOCHROMIC MOLECULES | UACA, DCLRE1A, RAD54L | KDM4E 3162/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.